Authors


Trudy F. Grande, CFP

Latest:

Permanent life insurance is still your guardian angel

Q With the repeal of the future estate tax, do you think it is still necessary for me to continue paying the permanent life insurance premiums on the policies that I originally purchased to pay federal estate taxes?



Mark L. Dlugoss

Latest:

Editor's Blog: Can ophthalmology find technological 'global harmony'?

In today's blog from ESCRS, Mark Dlugoss, Ophthalmology Times editor-in-chief, discusses ophthalmic technologies and FDA-related availability issues.



Spencer Thornton, MD

Latest:

Nutrients restore tear function in dry eye syndrome

The paradigm of dry eye treatment is the use of solutions and lubricants applied to the eye. That is, dry eyes require topical medication in the form of artificial tears to restore tear production and comfort. Anything other than this is contrary to belief and intuition and a paradigm shift.


Pamela B. Fritz

Latest:

Another success for AADO's conference in NYC

Building on its continuing relationship with International Vision Expo, the American Association of Dispensing Ophthalmologists (AADO) has seen consistently increasing attendance at its educational conferences by both ophthalmologists and their practice and optical dispensary management staff.


John Nemec

Latest:

Getting a clearer vision of the refractive marketplace

Sacramento, CA-As the boom in LASIK surgery recedes, refractive surgeons risk major declines in numbers of patients unless they understand marketing concepts that will help them find and attract potential clients, according to Glenn Hagele.


Jeffrey J. Denning

Latest:

In search of answers to your questions

Practice consultants can be a cost-effective way to get the solution to a problem. They bring specialized knowledge you can "rent" by the hour. But will the advice be worth the cost? Whenever you purchase something expensive, you should ask the same question: What's the return I expect from this investment?


Ed Edelson

Latest:

New drugs, techniques promising, but more data needed

New York-Some antifibrosis drugs and techniques on the horizon appear promising, but more data, especially from controlled human trials, are needed, Paul J. Lama, MD, told those attending the Glaucoma 2006 meeting here.


Norman B. Medow, MD, FACS

Latest:

Pioneer of ophthalmic plastic surgery followed his calling

Editor's Note: During the time I was a resident at Manhattan Eye, Ear and Throat Hospital (1969-1972), I had the good fortune to work with Byron Capleese Smith, MD. Those who knew him will never forget him, and those who were not able to know him will gain a small glimpse of his persona and his contributions, as written by Christopher Teng, MD. -Norman Medow, MD


H. Jay Wisnicki, MD

Latest:

Wireless networking transforms health care

Technology is often seen as a means to decrease human interaction. Try calling your bank for an account balance. You may be irritated with the number of buttons you have to push to hear a computerized human voice return the numbers. Or a trip to the automated teller machine enables a simple bank transaction, but eliminates the chitchat with the neighborhood teller. While such technology may lack the "human touch," it does enhance the ability of the company to operate more efficiently.


Susanne Medeiros

Latest:

AAO's O.N.E. source for online education and resources

The academy has created a comprehensive online educational resource center for ophthalmologists. The Ophthalmic News & Education Network or O.N.E. is a powerful resource that will allow the Academy to share more of its resources with ophthalmologists around the world, helping them deliver the best possible eye care.


Andrew G. Lee, MD

Latest:

VLOG: NeuroOp Guru: Susac syndrome and fluorescein angiogram

Andrew Lee, MD, and Andrew Carey, MD, sit down on another episode of the NeuroOp Guru to discuss Susac syndrome, and how leakage on fluorescein angiogram might be the most sensitive marker of activity of disease.




Nancy Groves

Latest:

Flying solo poses challenges, flexibility and support vital

Operating a small practice may require physicians to wear many hats


Laszlo Dosa

Latest:

Creation of retinochoroidal anastomosis may help those with CRVO

Mexico City-Surgical treatment of central retinal vein occlusion (CRVO) by the creation of retinochoroidal anastomosis (RCA) may become an effective therapy for some patients with CRVO, according to Hugo Quiroz-Mercado, MD.


Ralph D. Levinson, MD

Latest:

Biologic agents treat ocular inflammatory disease

Editor's Note: As defined by the FDA, the term "biologics" refers to a wide range of products that includes vaccines, blood and blood components, allergenics, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins, such as monoclonal antibodies and antibody fragments.


Jennifer Hanni

Latest:

Finding Balance

For Robert Abel, MD, a curiosity about Eastern philosophy has led to greater balance in his life. Since he began participating in Tai Chi, his life has become more enjoyable and grounded.


Richard J. Duffey, MD

Latest:

Femtosecond laser provides option of thinner LASIK flaps

There has been a recent trend toward thinner flaps for LASIK to decrease the risk of corneal ectasia following surgery. Other advantages exist as well for patients undergoing thin-flap LASIK.


Cheryl Guttman Krader, BS, Pharm

Latest:

Primary posterior optic capture offers many advantages in cataract surgery

Approach enables patients to maintain best possible vision with one-time only procedure


Stephen S. Lane, MD

Latest:

Ophthalmic viscosurgical device choices mean optimized outcomes

The large variety of available OVDs allows the surgeon to tailor the surgery to meet any specific needs a patient may have.


Mark Packer, MD,FACS

Latest:

Surgeon offers pearls for the EVO Visian ICL

According to Mark Packer, MD, FACS, observations include key data points and clinical implications.


William H. Bearden, MD

Latest:

Exposures of porous orbital implants can be avoided

In the past decade, porous orbital implants have become the implant of choice for many surgeons managing the anophthalmic socket after enucleation or evisceration. By permitting fibrovascular ingrowth, these porous implants are better able to resist infection, migration, and extrusion when compared with acrylic or silicone implants.


Joseph F. Mussoline, MD

Latest:

Dry-eye drops and the different implications for patients

Important differences exist between the various classes of over-the-counter eye drops. Physicians play a vital role in explaining these differences, as well as their potential implications in the treatment of the symptoms of dry eye and other conditions, to patients. Educating patients about the available formulations not only may expedite the relief of their symptoms but also may save them time and money.


Richard L. Anderson, MD, FACS

Latest:

Being an oculoplastic surgeon is a deliberate choice

Recently, I have heard oculoplastic surgeons voicing their concerns about the future of our profession. Many advise de-specializing to try to compete with other plastic surgeons. I advise trying to be the best in our area of expertise. We are privileged to be in the best specialty in medicine.


George L. Mayo, MD

Latest:

Inhaled cocaine use linked to nonischemic vascular event

A 42-year-old Hispanic male presented complaining of decreased vision in his left eye. He noted that his vision in that eye had decreased suddenly three weeks earlier. The patient had low hyperopia. His medical, surgical, and family histories were unremarkable. He was using no medications and had no known drug allergies. Although he initially reported no significant social history, after more extensive questioning he admitted to the occasional inhalational use of cocaine. His most recent use was on the day prior to the onset of his visual disturbance.


Arun C. Gulani, MD

Latest:

LaZrPlastique: The non–cutting edge over LASIK

Procedure offers sharp contrast to cutting procedures without risk, pain, or drama.


Allen C. Ho, MD

Latest:

Medicare fee schedule is déjà vu all over again

Using recent history as a guide, will Medicare cut physician payments by 24% in 2014?


© 2024 MJH Life Sciences

All rights reserved.